Lompostrans vision is to be a global leader in the production of high quality, safe and efficacious Cannabis derived products. Our product portfolio, of cannabis derived products, will support the current market demand for EU-GMP dried flower, and the on-going current shift from the use of Cannabis flower to pharmaceutical grade finished dosage forms. Lompostran is strategically positioning itself to be a critical partner/service provider in the Portuguese supply chain of Medicinal Cannabis products to serve the EU Market. Our contract manufacturing services such as drying, sanitization, packaging, storage, analysis, and batch disposition of Cannabis-based products will create a roadmap for all Portuguese cultivators to access the European Medical market without the need for large CAPEX investment, staffing and infrastructure. Our scalable, flexible process solutions allow Lompostran to manufacture tailored products from Cannabis plant material that would otherwise not meet the quality requirements of the EU medical Cannabis market. In essence, we pair our expertise with our client's vision to bring their product to the market.Our fully integrated solutions allow cultivators to transform GACP Cannabis to a pharmaceutical (GMP) product by availing of our contract manufacturing services. Furthermore, our pharmaceutical partners and clients have confidence in the knowledge that all pharmaceutical industry standards and controls are used in the manufacture of our products.